These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34572945)

  • 1. Reproducibility of mRNA-Based Testing of
    Erber R; Hartmann A; Fasching PA; Ruebner M; Stöhr R; Beckmann MW; Zentgraf M; Popp V; Weidler J; Simon I; Becker S; Huebner H; Fischer J; Guerini Rocco E; Viale G; Cayre A; Penault-Llorca F; Caniego Casas T; Pérez-Miés B; Palacios J; Jank P; Denkert C; Khoury L; Mairinger T; Ferrazzi F
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6.
    Filipits M; Rudas M; Singer CF; Fitzal F; Bago-Horvath Z; Greil R; Balic M; Lax SF; Halper S; Hulla W; Wu NC; Liu X; Weidler J; Bates M; Hlauschek D; Gnant M; Dubsky P
    ESMO Open; 2021 Aug; 6(4):100228. PubMed ID: 34371382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform.
    Wu NC; Wong W; Ho KE; Chu VC; Rizo A; Davenport S; Kelly D; Makar R; Jassem J; Duchnowska R; Biernat W; Radecka B; Fujita T; Klein JL; Stonecypher M; Ohta S; Juhl H; Weidler JM; Bates M; Press MF
    Breast Cancer Res Treat; 2018 Nov; 172(2):327-338. PubMed ID: 30120700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the Xpert Breast Cancer STRAT4 for Biomarker Evaluation in Tissue Processed in a Developing Country.
    Mugabe M; Ho KE; Ruhangaza D; Milner D; Rugwizangoga B; Chu VC; Wu NC; Rizo A; Weidler JM; Wong W; Bates M; Brock JE
    Am J Clin Pathol; 2021 Oct; 156(5):766-776. PubMed ID: 34050358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of
    Carretero-Barrio I; Caniego-Casas T; Rosas M; Sánchez MC; Martínez-Jáñez N; Chiva M; Sarrió D; Moreno-Bueno G; Palacios J; Pérez-Mies B
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of breast cancer surrogate subtyping using a closed-system RT-qPCR breast cancer assay and immunohistochemistry on 100 core needle biopsies with matching surgical specimens.
    Janeva S; Parris TZ; Nasic S; De Lara S; Larsson K; Audisio RA; Olofsson Bagge R; Kovács A
    BMC Cancer; 2021 Apr; 21(1):439. PubMed ID: 33879115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens.
    Laible M; Schlombs K; Kaiser K; Veltrup E; Herlein S; Lakis S; Stöhr R; Eidt S; Hartmann A; Wirtz RM; Sahin U
    BMC Cancer; 2016 Jul; 16():398. PubMed ID: 27389414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer.
    Chen L; Chen Y; Xie Z; Luo J; Wang Y; Zhou J; Huang L; Li H; Wang L; Liu P; Shu M; Zhang W; Ke Z
    Breast Cancer Res Treat; 2022 Aug; 194(3):517-529. PubMed ID: 35789315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Xpert Breast Cancer STRAT 4 Assay on the GeneXpert instrument to Assess Hormone Receptor, Ki67, and HER2 Gene Expression Status in Breast Cancer Tissue Samples.
    Sewanywa L; Hale M; Michelow P; Mayne E; Wiggill T
    Appl Immunohistochem Mol Morphol; 2023 Oct; 31(9):613-620. PubMed ID: 37800656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®.
    Varga Z; Lebeau A; Bu H; Hartmann A; Penault-Llorca F; Guerini-Rocco E; Schraml P; Symmans F; Stoehr R; Teng X; Turzynski A; von Wasielewski R; Gürtler C; Laible M; Schlombs K; Joensuu H; Keller T; Sinn P; Sahin U; Bartlett J; Viale G
    Breast Cancer Res; 2017 May; 19(1):55. PubMed ID: 28490348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
    Sinn HP; Schneeweiss A; Keller M; Schlombs K; Laible M; Seitz J; Lakis S; Veltrup E; Altevogt P; Eidt S; Wirtz RM; Marmé F
    BMC Cancer; 2017 Feb; 17(1):124. PubMed ID: 28193205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry.
    Wirtz RM; Sihto H; Isola J; Heikkilä P; Kellokumpu-Lehtinen PL; Auvinen P; Turpeenniemi-Hujanen T; Jyrkkiö S; Lakis S; Schlombs K; Laible M; Weber S; Eidt S; Sahin U; Joensuu H
    Breast Cancer Res Treat; 2016 Jun; 157(3):437-46. PubMed ID: 27220750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XPERT
    Borges PCC; Spencer HB; Barbosa C; Costa V; Furtado A; Leal MC; Lopes C; Ferreira D; Carvalho AL; Dos-Santos-Silva I; Santos LL
    Ecancermedicalscience; 2023; 17():1530. PubMed ID: 37138965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC).
    Breyer J; Wirtz RM; Laible M; Schlombs K; Erben P; Kriegmair MC; Stoehr R; Eidt S; Denzinger S; Burger M; Hartmann A; Otto W
    Virchows Arch; 2016 Nov; 469(5):547-552. PubMed ID: 27514658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer Subtype Classification Using 4-Plex Droplet Digital PCR.
    Chen W; Zheng J; Wu C; Liu S; Chen Y; Liu X; Du J; Wang J
    Clin Chem; 2019 Aug; 65(8):1051-1059. PubMed ID: 31010819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive and Accurate Molecular Profiling of Breast Cancer through mRNA Expression of
    Wegscheider AS; Gorniak J; Rollinson S; Gough L; Dhaliwal N; Guardiola A; Gasior A; Helmer D; Pounce Z; Niendorf A
    Diagnostics (Basel); 2024 Jan; 14(3):. PubMed ID: 38337757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of ESR1/PGR/ERBB2 mRNA levels by RT-QPCR: a better approach for subtyping breast cancer and predicting prognosis.
    Du X; Li XQ; Li L; Xu YY; Feng YM
    Breast Cancer Res Treat; 2013 Feb; 138(1):59-67. PubMed ID: 23397283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor biomarker conversion between primary and metastatic breast cancer: mRNA assessment and its concordance with immunohistochemistry.
    Stefanovic S; Wirtz R; Deutsch TM; Hartkopf A; Sinn P; Varga Z; Sobottka B; Sotiris L; Taran FA; Domschke C; Hennigs A; Brucker SY; Sohn C; Schuetz F; Schneeweiss A; Wallwiener M
    Oncotarget; 2017 Aug; 8(31):51416-51428. PubMed ID: 28881657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated Classification of Breast Cancer Across the Spectrum of
    Guvakova MA
    JCO Clin Cancer Inform; 2023 Jul; 7():e2300013. PubMed ID: 37437225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.